Original Article

CME Article: Value of Troponin in Predicting Hospital Mortality of Older Adult Patients without Suspected Acute Coronary Syndromes

Authors: Zvi Shimoni, MD, Paul Froom, MD, Jochanan Benbassat, MD

Abstract

Objectives: Some authors have recommended troponin measurement to stratify patient mortality risk, but it is unclear whether troponin values add to age and routine admission laboratory tests in the prediction of in-hospital mortality of older adult patients without suspected acute coronary syndrome (ACS). The aim of our study was to determine whether troponin testing adds significantly to routine admission laboratory testing in predicting in-hospital mortality in patients without a suspected ACS.

Methods: In 2018–2019, we reviewed all acutely admitted patients aged 60 years or older to Internal Medicine wards of a regional hospital after excluding those admitted to intensive care or with chest pain. The independent variables were troponin, age, sex, and routine admission laboratory tests. The outcome measure was in-hospital mortality. We compared c-statistics and the observed 10% to 90% risk gradients using logistic regression models for age and routine laboratory testing before and after the addition of troponin.

Results: The mortality risk gradient for age and admission laboratory tests was 0.2% to 29.5%. Adding troponin did not increase the gradient significantly (0.2%–34.6%, P = 0.170), and the 95% confidence intervals for the c-statistics overlapped, increasing from 0.845 (0.818–0.876) to 0.866 (0.839–0.892).

Conclusions: In older adult patients without suspected ACS, troponin testing did not improve the prediction of hospital mortality above that of a model including age and common admission blood tests. In the absence of suspected ACS, troponin testing is not needed to predict the hospital mortality of older adult patients.
Posted in: Cardiovascular Disease22

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Shimoni Z, Arbuzov R, Froom P. Troponin testing in patients without chest pain or electrocardiographic ischemic changes. Am J Med 2017;130:1205–1210.
 
2. Makam AN, Nguyen OK. Use of cardiac biomarker testing in the emergency department. JAMA Intern Med 2015;175:67–75.
 
3. Shimoni Z, Froom P. Decreasing the overuse of troponin testing—an interventional study in a regional hospital. Am J Med 2020;133:1433–1436.
 
4. Lippi G, Cervellin G. Clinical interpretation of high-sensitivity troponin testing. JAMA Intern Med 2019;179:725–726.
 
5. Shah ASV, Sandoval Y, Noaman A, et al. Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ 2017;359:j4788.
 
6. Wilson G, Barkley K, Slicker K, et al. Overuse of troponin? A comprehensive evaluation of testing in a large hospital system. J Hosp Med 2017;12:329–331.
 
7. Farber AJ, Suarez K, Slicker K, et al. Frequency of troponin testing in inpatient versus outpatient settings. Am J Cardiol 2017;119:1153–1155.
 
8. Talebi S, Ferra RM, Tedla S, et al. Hazards with ordering troponin in patients with low pretest probability of acute coronary syndrome. Am J Emerg Med 2015;33:1258–1260.
 
9. Roset A, Jacob J, Herrero-Puente P, et al. High-sensitivity cardiac troponin T 30 days all-come mortality in patients with acute heart failure. A propensity score-matching analysis based on the EAHFE Registry. TROPICA4 Study. Eur J Clin Invest 2020;50:e13248.
 
10. Atzema CL, Dorian P, Fang J, et al. A clinical decision instrument to predict 30-day death and cardiovascular hospitalizations after an emergency department visit for atrial fibrillation: The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) study. Am Heart J 2018; 203:85–92.
 
11. Probst MA, Gibson T, Weiss RE, et al. Risk stratification of older adults who present to the emergency department with syncope: the FAINT score. Ann Emerg Med 2020;75:147–158.
 
12. Melki D, Lugnegård J, Alfredsson J, et al. Implications of introducing high-sensitivity cardiac troponin t into clinical practice: data from the SWEDEHEART registry. J Am Coll Cardiol 2015;65:1655–1664.
 
13. Etaher A, Nguyen TL, Saad YM, et al. Mortality at 5 years among very elderly patients undergoing high sensitivity troponin t testing for suspected acute coronary syndromes. Heart Lung Circ 2020;29:1696–1703.
 
14. Stein GY, Alon D, Korenfeld R, et al. Clinical implications of high-sensitivity cardiac troponin measurements in hospitalized medical patients. PLoS One 2015;10:e0117162.
 
15. McFalls EO, Larsen G, Johnson GR, et al. Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am J Med. 2011;124:630–635.
 
16. Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag 2011;7:597–603.